SOD1 and Parkinson disease: Li et al. demonstrated that BACE1-AS is overexpressed in PD, and BACE1-AS downregulation reduced MDA and inducible nitric oxide synthase levels; increased GSH-PX, SOD, and DA levels; inhibited the apoptosis of SN neurons in PD rats; and improved oxidative stress injury.